Clinical trials for Cancer in United States

Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches

Study ID: NCT06495580

Sponsor

University of California, San Francisco

Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and Sézary Syndrome

Study ID: NCT05944562

Sponsor

Washington University School of Medicine

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Study ID: NCT06541262

Sponsor

Milton S. Hershey Medical Center

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Study ID: NCT05064280

Sponsor

M.D. Anderson Cancer Center

Collection and Distribution of Biospecimens for Novel Research Uses

Study ID: NCT03848962

Sponsor

iSpecimen Inc

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Study ID: NCT05668962

Sponsor

Massachusetts General Hospital

A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies

Study ID: NCT06413680

Sponsor

Regeneron Pharmaceuticals

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Study ID: NCT06445062

Sponsor

Revolution Medicines, Inc.

An Ophthalmic Safety Study in Patients With Breast Cancer

Study ID: NCT06767462

Sponsor

AstraZeneca

Liver Cancer Prevention Randomized Control Trial

Study ID: NCT05196867

Sponsor

M.D. Anderson Cancer Center